Mandate

Vinge advises Amundi in connection with the acquisition of Lyxor Asset Management from Société Générale for EUR 825 million

Vinge has advised Amundi, a division of the Crédit Agricole group, in connection with its acquisition of Lyxor from Société Générale.

Lyxor is a pioneer within, and the third largest actor in Europe with regard to exchange‑traded funds (ETFs), and via this acquisition Amundi will thereby strengthen its position as the European lead actor in the fast‑growing market for ETFs. The transaction is subject to customary approvals by public authorities and is expected to be completed not later than February 2022.

Vinge’s team consisted of responsible partner Fredrik Wilkens (Project Manager), Henrik SchönAnton Sjökvist (Fund Issues), Åsa GotthardsonSara Strandberg and Ebba Svenburg (Employment Law), Maria Schultzberg, Henrik Wastenson and Karolin Ekström (Tax) as well as Ulf Nilsson (VAT).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026

Vinge has advised Resurs in connection with its strategic partnership with Kustom

Vinge has advised Resurs in connection with its strategic partnership with Kustom (formerly Klarna Checkout), a fast-growing player in the digital commerce sector. The partnership enables Resurs to accelerate its strategic development by offering a check-out solution to its merchants, built on Kustom’s market-leading infrastructure.
March 25, 2026